Legend Biotech Corporation (FRA:9LB)

Legend Biotech Statistics

Total Valuation

Legend Biotech has a market cap or net worth of EUR 2.70 billion. The enterprise value is 2.23 billion.

Market Cap	2.70B
Enterprise Value	2.23B

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.80%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	81.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	62.26
PS Ratio	3.08
PB Ratio	3.16
P/TBV Ratio	3.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.83
EV / Sales	2.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-20.35

Financial Position

The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.41.

Current Ratio	1.96
Quick Ratio	1.88
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	-3.21
Interest Coverage	-6.38

Financial Efficiency

Return on equity (ROE) is -29.06% and return on invested capital (ROIC) is -30.47%.

Return on Equity (ROE)	-29.06%
Return on Assets (ROA)	-5.01%
Return on Invested Capital (ROIC)	-30.47%
Return on Capital Employed (ROCE)	-12.44%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	302,177
Profits Per Employee	-87,167
Employee Count	2,900
Asset Turnover	0.60
Inventory Turnover	29.44

Taxes

In the past 12 months, Legend Biotech has paid 12.09 million in taxes.

Income Tax	12.09M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-54.06%
50-Day Moving Average	15.58
200-Day Moving Average	24.63
Relative Strength Index (RSI)	38.84
Average Volume (20 Days)	8

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.89

Income Statement

In the last 12 months, Legend Biotech had revenue of EUR 876.31 million and -252.78 million in losses. Loss per share was -1.38.

Revenue	876.31M
Gross Profit	175.54M
Operating Income	-116.26M
Pretax Income	-240.69M
Net Income	-252.78M
EBITDA	-108.25M
EBIT	-116.26M
Loss Per Share	-1.38

Balance Sheet

The company has 807.92 million in cash and 352.35 million in debt, with a net cash position of 455.57 million.

Cash & Cash Equivalents	807.92M
Total Debt	352.35M
Net Cash	455.57M
Net Cash Per Share	n/a
Equity (Book Value)	853.49M
Book Value Per Share	4.61
Working Capital	520.13M

Cash Flow

In the last 12 months, operating cash flow was -85.34 million and capital expenditures -24.36 million, giving a free cash flow of -109.70 million.

Operating Cash Flow	-85.34M
Capital Expenditures	-24.36M
Depreciation & Amortization	8.14M
Net Borrowing	-3.12M
Free Cash Flow	-109.70M
FCF Per Share	n/a

Margins

Gross margin is 20.03%, with operating and profit margins of -13.27% and -28.85%.

Gross Margin	20.03%
Operating Margin	-13.27%
Pretax Margin	-27.47%
Profit Margin	-28.85%
EBITDA Margin	-12.35%
EBIT Margin	-13.27%
FCF Margin	n/a

Dividends & Yields

Legend Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.80%
Shareholder Yield	-0.80%
Earnings Yield	-9.37%
FCF Yield	-4.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Legend Biotech has an Altman Z-Score of 4.22 and a Piotroski F-Score of 3.

Altman Z-Score	4.22
Piotroski F-Score	3